Anheuser-Busch InBev SA/NV (LON:0RJI)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,167	11,174	10,332	9,973	12,097	15,252
Short-Term Investments	205	221	67	97	374	396
Cash & Short-Term Investments	7,372	11,395	10,399	10,070	12,471	15,648
Cash Growth	-3.56%	9.58%	3.27%	-19.25%	-20.30%	113.48%
Accounts Receivable	4,911	3,852	4,417	3,707	3,564	3,401
Other Receivables	2,168	1,652	1,955	2,026	1,513	1,733
Receivables	7,079	5,504	6,372	5,733	5,077	5,134
Inventory	5,475	5,020	5,583	6,612	5,399	4,482
Prepaid Expenses	787	493	474	410	350	354
Other Current Assets	502	587	539	361	652	901
Total Current Assets	21,215	22,999	23,367	23,186	23,949	26,519
Property, Plant & Equipment	23,854	23,503	26,818	26,671	26,678	26,419
Long-Term Investments	5,030	4,780	5,050	4,831	6,035	6,280
Goodwill	114,782	110,479	117,043	113,010	115,796	120,971
Other Intangible Assets	41,096	40,034	41,286	40,209	40,430	41,527
Long-Term Accounts Receivable	259	220	282	308	336	382
Long-Term Deferred Tax Assets	2,730	2,493	2,935	2,300	1,969	2,019
Other Long-Term Assets	2,141	2,129	2,559	2,428	2,434	2,293
Total Assets	211,107	206,637	219,340	212,943	217,627	226,410
Accounts Payable	22,188	16,010	17,729	18,589	17,810	15,898
Accrued Expenses	-	6,536	7,036	6,728	6,724	6,064
Short-Term Debt	21	-	17	83	53	1,527
Current Portion of Long-Term Debt	3,074	975	3,308	692	1,059	1,426
Current Portion of Leases	589	556	703	529	447	397
Current Income Taxes Payable	1,386	1,805	1,583	1,438	1,334	1,036
Current Unearned Revenue	-	-	-	-	-	27
Other Current Liabilities	5,751	7,184	6,780	6,324	6,757	5,977
Total Current Liabilities	33,009	33,066	37,156	34,383	34,184	32,352
Long-Term Debt	70,408	69,038	72,187	76,917	85,539	93,641
Long-Term Leases	1,745	1,748	2,126	1,963	1,830	1,837
Long-Term Deferred Tax Liabilities	11,385	11,321	11,874	11,818	12,204	12,627
Other Long-Term Liabilities	1,859	1,468	1,648	2,050	2,269	4,632
Total Liabilities	119,693	117,937	126,664	128,665	138,287	148,059
Common Stock	1,736	1,736	1,736	1,736	1,736	1,736
Additional Paid-In Capital	17,620	17,620	17,620	17,620	17,620	17,620
Retained Earnings	47,641	46,577	42,215	38,823	33,882	30,870
Treasury Stock	-5,024	-3,886	-3,465	-3,706	-3,994	-4,911
Comprehensive Income & Other	18,698	16,190	23,742	18,925	19,425	22,709
Total Common Equity	80,671	78,237	81,848	73,398	68,669	68,024
Minority Interest	10,743	10,463	10,828	10,880	10,671	10,327
Shareholders' Equity	91,414	88,700	92,676	84,278	79,340	78,351
Total Liabilities & Equity	211,107	206,637	219,340	212,943	217,627	226,410
Total Debt	75,837	72,317	78,341	80,184	88,928	98,828
Net Cash (Debt)	-68,465	-60,922	-67,942	-70,114	-76,457	-83,180
Net Cash Per Share	-33.64	-29.81	-33.08	-34.20	-37.39	-41.63
Filing Date Shares Outstanding	1,953	1,975	1,984	1,984	1,981	1,972
Total Common Shares Outstanding	1,953	1,975	1,984	1,984	1,981	1,972
Working Capital	-11,794	-10,067	-13,789	-11,197	-10,235	-5,833
Book Value Per Share	41.31	39.61	41.26	37.00	34.66	34.49
Tangible Book Value	-75,207	-72,276	-76,481	-79,821	-87,557	-94,474
Tangible Book Value Per Share	-38.52	-36.59	-38.55	-40.24	-44.20	-47.90
Land	13,024	12,325	13,071	12,591	12,374	12,237
Machinery	40,543	38,055	39,782	37,473	35,907	34,976
Construction In Progress	1,121	1,166	1,669	2,205	2,462	1,780

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.